Literature DB >> 12763925

Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium.

Thomas Baltus1, Kim S C Weber, Zoë Johnson, Amanda E I Proudfoot, Christian Weber.   

Abstract

Chemokines control inflammatory leukocyte recruitment. The propensity of chemokines such as CC chemokine ligand 5 (CCL5)/RANTES (regulated on activation, normal T cell expressed and secreted) to bind to glycosaminoglycans and to form higher order oligomers has been shown to be essential for its in vivo activity. However, the specific functional relevance of RANTES oligomerization for distinct steps of leukocyte recruitment on inflamed endothelium mediated by the RANTES receptors CC chemokine receptor 1 (CCR1) and CCR5 remains undefined. We studied RANTES mutants with deficient oligomerization in an assay in which recruitment of monocytes and CD45RO+ CD4+ T cells is triggered by RANTES immobilized on activated endothelium under flow conditions. Notably, the formation of higher order RANTES oligomers was crucial for CCR1-mediated arrest but not for CCR5-mediated spreading/transmigration in flow or transendothelial chemotaxis of leukocytes. Efficient leukocyte arrest in flow but not transmigration may thus require the presentation of RANTES oligomers to bridge surface-bound RANTES and CCR1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763925     DOI: 10.1182/blood-2003-04-1175

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  Platelets: a critical link between inflammation and microvascular dysfunction.

Authors:  Karen Y Stokes; D Neil Granger
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

Review 2.  Therapeutic strategies to deplete macrophages in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Guido R Y De Meyer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

Review 3.  Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.

Authors:  Lavanya Rajagopalan; Krishna Rajarathnam
Journal:  Biosci Rep       Date:  2006-10       Impact factor: 3.840

Review 4.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

Review 5.  Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.

Authors:  C L Salanga; T M Handel
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

Review 6.  Chemokine receptor oligomerization and allostery.

Authors:  Bryan Stephens; Tracy M Handel
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 7.  Therapeutic targeting of chemokine interactions in atherosclerosis.

Authors:  Rory R Koenen; Christian Weber
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

8.  Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data.

Authors:  Xu Wang; Caroline Watson; Joshua S Sharp; Tracy M Handel; James H Prestegard
Journal:  Structure       Date:  2011-08-10       Impact factor: 5.006

9.  Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.

Authors:  Wenguang G Liang; Catherine G Triandafillou; Teng-Yi Huang; Medel Manuel L Zulueta; Shiladitya Banerjee; Aaron R Dinner; Shang-Cheng Hung; Wei-Jen Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

10.  Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.

Authors:  L Heggelund; J K Damås; A Yndestad; A M Holm; F Mūller; E Lien; T Espevik; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.